CBIO
CBIO
NASDAQ · Biotechnology

Crescent Biopharma Inc

$12.01
+1.57 (+15.04%)
As of Mar 25, 3:35 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +130.3% upside
Low Target $15.31
Average Target $27.66
High Target $30.74
Current Price $12.01
Current
$12.01
Target
$27.66
$15.31 $27.66 avg $30.74
Scenario Analysis
Bear Case
$15.31
27.5%
Low target
Base Case
$27.66
+130.3%
Avg target
Bull Case
$30.74
+156.0%
High target
Risk/Reward
5.7x
Highly favorable
Price in Context
52-Week High
$26.97
-55.5% from high
52-Week Low
$14.78
+-18.7% from low
Target vs 52W High
$27.66
+2.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%